|
Real-time
Euronext Paris
17:57:51 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4490 EUR | -4.47% |
|
-19.82% | -61.88% |
| 10-22 | NFL Biosciences SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-22 | NFL Biosciences Gets Regulatory Approvals to Begin Phase 2 Nicotine Cessation Trial for NFL-102 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NFL BIOSCIENCES | Bio Therapeutic Drugs | -4.47% | -19.82% | -61.88% | -60.20% | -88.66% | 6.66M |  | | |
- Stock Market
- Stocks
- ALNFL Stock
- Charts NFL Biosciences
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
